Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis

Y. Park (Seoul, Republic of Korea), E. Lee (Seoul, Republic of Korea), I. Jung (Seoul, Republic of Korea), G. Park (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea)

Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Session: Clinical investigations of non-TB mycobacterial infection
Session type: Thematic Poster
Number: 2932
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Park (Seoul, Republic of Korea), E. Lee (Seoul, Republic of Korea), I. Jung (Seoul, Republic of Korea), G. Park (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea). Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis. 2932

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study
Source: Eur Respir J 2004; 24: Suppl. 48, 721s
Year: 2004

Clinical efficacy and safety of fluoroquinolone containing regimens in patients with Mycobacterium avium complex pulmonary disease
Source: Eur Respir J, 55 (4) 1901240; 10.1183/13993003.01240-2019
Year: 2020



The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study
Source: Eur Respir J, 56 (3) 1901875; 10.1183/13993003.01875-2019
Year: 2020



Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
Source: Eur Respir J, 54 (1) 1801991; 10.1183/13993003.01991-2018
Year: 2019



Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017



Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003



Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017


Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Clinical analysis of pulmonary Mycobacterium kansasii disease
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018

Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005



Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018



The effect of combined chemotherapy according to the guidelines on the treatment for Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002

Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy following the guidelines for treatment
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009


Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

Treatment of human disease due to Mycobacterium bovis: a systematic review
Source: Eur Respir J 2016; 48: 1500-1503
Year: 2016


Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022



Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Mycobacterium abscessus infection in lung transplant patients: review of our series
Source: Annual Congress 2007 - Complications and success in lung transplantation
Year: 2007


Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease
Source: Eur Respir J, 58 (2) 1902269; 10.1183/13993003.02269-2019
Year: 2021